Federal Register Notice: FDA has determined that Metadate ER (methylphenidate hydrochloride) extended-release tablet, 10 mg was not withdrawn from sale for reasons of safety or effectiveness. This will allow FDA to approve ANDAs for methylphenidate HCl extended-release tablet, 10 mg, if all other legal and regulatory requirements are met. To view this notice, click here.
